mTORC1通路参与了B细胞在免疫性血栓塞缩小症中的高功能
Yujiao Xiang1, Lu Liu1,2, Yu Hou1,3,2
1Department of Hematology, Qilu Hospital of Shandong University, Jinan, China.
Annals of hematology
|July 8, 2023
概括
在免疫性血栓缩 (ITP) 中,B细胞过度活跃,导致疾病. 用像拉巴胺这样的抑制剂向mtORC1通路可能会恢复正常的B细胞功能,并提供一种新的ITP治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在ITP的病原性.
背景情况:
- B细胞的高功能导致免疫血小板缩 (ITP) 的发病.
- 在ITP中驱动B细胞功能障碍的精确分子机制在很大程度上是未知的.
研究的目的:
- 为了确定ITP患者B细胞功能障碍的分子调节剂.
- 为了研究mTOR途径在ITP病变发生中的作用.
- 探索潜在的治疗策略,针对ITP中的B细胞高功能.
主要方法:
- 从25名ITP患者的外周血液单核细胞 (PBMC) 中分离B细胞.
- 转录组测序以识别失调的基因和途径.
- 在体外实验中使用mTOR抑制剂 (拉帕米辛,Torin1) 来评估它们对B细胞功能的影响.
主要成果:
- ITP B细胞表现出增加的抗体产生,增强的终端分化,和调高的CD80/CD86共刺激分子.
- RNA测序揭示了致病性ITP B细胞中高度激活的mTOR通路.
- 拉巴胺素或Torin1的mTORC1抑制降低了抗体分泌,降低了血细胞分化,降低了辅助刺激分子的调节.
结论:
- 拉巴胺素复合体1 (mTORC1) 途径的机械性标被激活在 ITP 患者的 B 细胞中,并导致 B 细胞的高功能.
- 抑制mTORC1通路通过调节异常B细胞活性来证明ITP的治疗潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Extrinsic and Intrinsic Pathways of Hemostasis
8.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.4K
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
TGF - β Signaling Pathway
7.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.5K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Cytotoxic T Cells-mediated Immune Response
995
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
995


